RMD ResMed Inc

$281.40

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending
Expected on
Report Time: Unknown Release Time
The Whisper Number
Consensus Estimate:
Revenue Estimate:

Latest Earnings Insight

Updated On 10/6/2025

About ResMed Inc

ResMed is a San Diego, California-based medical equipment company. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea (such as CPAP devices and masks), chronic obstructive pulmonary disease (COPD), and other respiratory conditions.

Website: https://www.resmed.com

Sector
LIFE SCIENCES
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NYSE
Country
USA
Currency
USD
Fiscal Year End
June
CIK
943819
Address
9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA, US
Valuation
Market Cap
$31.27B
P/E Ratio
25.14
PEG Ratio
1.39
Price to Book
5.95
Performance
EPS
$8.47
Dividend Yield
1.00%
Profit Margin
25.40%
ROE
25.70%
Technicals
50D MA
$224.84
200D MA
$231.53
52W High
$262.46
52W Low
$176.89
Fundamentals
Shares Outstanding
147M
Target Price
$266.15
Beta
0.76

RMD EPS Estimates vs Actual

Estimated
Actual

RMD News & Sentiment

Oct 02, 2025 • Zacks Commentary BULLISH
Why ResMed ( RMD ) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Oct 02, 2025 • Zacks Commentary BULLISH
Nyxoah Expands in the Middle East to Provide Wider Access to Genio
NYXH expands in the Middle East after Abu Dhabi's first Genio implant, aiming to broaden access for OSA patients.
Sep 24, 2025 • Zacks Commentary BULLISH
Add These 4 GARP Stocks to Your Portfolio to Receive Handsome Returns
The GARP strategy helps investors gain exposure to stocks that have solid prospects and are trading at a discount. GE, RMD, VRT and NFG are some such stocks.
Sep 18, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Baxter Stock Slips Despite Latest Launch to Boost Patient Monitoring
BAX launches FDA-cleared Connex 360 monitor, aiming to boost frontline care and streamline patient monitoring.
Sep 18, 2025 • Benzinga SOMEWHAT-BULLISH
This Target Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday - AeroVironment ( NASDAQ:AVAV ) , Abercrombie & Fitch ( NYSE:ANF )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Sep 16, 2025 • GlobeNewswire BULLISH
Resmed Announces Participation in the Bank of America Global Healthcare Conference 2025
SAN DIEGO, Sept. 16, 2025 ( GLOBE NEWSWIRE ) -- Resmed ( NYSE: RMD, ASX: RMD ) today announced Mick Farrell, chairman and chief executive officer, and Dr. Carlos Nunez, chief medical officer, will present at the Bank of America Global Healthcare Conference 2025 on Tuesday, September 23, 2025, ...
Sentiment Snapshot

Average Sentiment Score:

0.319
50 articles with scored sentiment

Overall Sentiment:

Bullish

RMD Reported Earnings

Apr 23, 2025
Mar 31, 2025 (Pre market)
0.01 Surprise
  • Reported EPS: $2.37
  • Estimate: $2.36
  • Whisper:
  • Surprise %: 0.4%
Jan 22, 2025
Dec 31, 2024 (Pre market)
0.11 Surprise
  • Reported EPS: $2.43
  • Estimate: $2.32
  • Whisper:
  • Surprise %: 4.7%
Oct 24, 2024
Sep 30, 2024 (Post market)
0.16 Surprise
  • Reported EPS: $2.20
  • Estimate: $2.04
  • Whisper:
  • Surprise %: 7.8%
Aug 01, 2024
Jun 30, 2024 (Post market)
0.01 Surprise
  • Reported EPS: $2.08
  • Estimate: $2.07
  • Whisper:
  • Surprise %: 0.5%
Apr 25, 2024
Mar 31, 2024 (Post market)
0.22 Surprise
  • Reported EPS: $2.13
  • Estimate: $1.91
  • Whisper:
  • Surprise %: 11.5%
Jan 24, 2024
Dec 31, 2023 (Post market)
0.08 Surprise
  • Reported EPS: $1.88
  • Estimate: $1.80
  • Whisper:
  • Surprise %: 4.4%
Oct 26, 2023
Sep 30, 2023 (Post market)
0.02 Surprise
  • Reported EPS: $1.64
  • Estimate: $1.62
  • Whisper:
  • Surprise %: 1.2%
Aug 03, 2023
Jun 30, 2023 (Post market)
-0.09 Surprise
  • Reported EPS: $1.60
  • Estimate: $1.69
  • Whisper:
  • Surprise %: -5.3%
Apr 27, 2023
Mar 31, 2023 (Post market)
0.09 Surprise
  • Reported EPS: $1.68
  • Estimate: $1.59
  • Whisper:
  • Surprise %: 5.7%

Financials